Neurocognition in Major Psychiatric Disorders:  Predictors and Clinical Implications

Katherine Burdick, Ph.D.

Introduction

Dr. Katherine E. Burdick is an Associate Professor of Psychiatry and Director of the Mood and Psychosis Research Program at Brigham and Women’s Hospital – Harvard Medical School. She has expertise in clinical and neurocognitive assessment across a range of patients with psychotic disorders, including schizophrenia and bipolar disorder.

Dr. Burdick holds a Ph.D. in Clinical Neuropsychology from the City University of New York-The Graduate Center. She completed her clinical internship and her postdoctoral fellowship at Yale University School of Medicine and is licensed in the state of New York.

Dr. Burdick’s primary research focus is on identifying persistent cognitive deficits in major psychiatric disorders, understanding their etiologies, and directly targeting them with treatment. She has received substantial grant support for this work from the National Institute of Mental Health (NIMH), Office of Veteran’s Affairs, and private foundations.

Learning Objectives

1. Characterize the cognitive profile common to bipolar disorder and compare it with that seen in schizophrenia.
2. Identify the clinical correlates and biomarkers of cognitive impairment in bipolar patients.
3. Describe the cognitive trajectory in bipolar disorder including both neurodevelopmental and neurodegenerative processes.

 
Live webcast available at:  http://videos.mayo.edu/live
1 AMA PRA Category 1 Credit(s)™ hour is offered for watching this Webcast live.  Ethos will be implemented for all post presentation surveys.  To document your attendance, please text the code given at the presentation to 507-200-3010.  For questions, email rstpsychgr@mayo.edu.

Credit Statements
• Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
• Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• The Department of Psychiatry and Psychology at Mayo Clinic, Rochester, is approved by the American Psychological Association to sponsor continuing education credits for psychologists. The Department of Psychiatry and Psychology at Mayo Clinic, Rochester maintains responsibility for this program and its content.
• Archived webcast available at: Psychiatry & Psychology Video Library
Industry Acknowledgment (if applicable): None.

NEW in 2017 !!!

All participants MUST complete the evaluation in order to get CME or APA Credit. 

1) Text the CODE announced at the session within 48 hours to (507) 200-3010
2) Login at ce.mayo.edu and go to My Account, My Courses, Registered Courses, click Session title and START to access the required Evaluation.
-or-
Click the START button on that session page.
3) Evaluation must be completed within 2 weeks.
 
Disclosure Summary
As a provider accredited by ACCME, Mayo Clinic College of Medicine and Science (Mayo Clinic School of Continuous Professional Development), must ensure balance, independence, objectivity and scientific rigor in its educational activities.   Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry:  Speaker:  Katherine Burdick, Ph.D: 

Consultant:  Takeda-Lundbeck; Neuralstem

No relevant financial relationship(s) with industry:
Brian Palmer, M.D., Michael Bostwick, M.D., Karen Grothe, Ph.D., Lois Krahn, M.D., Jarrod Leffler, Ph.D., Larissa Loukianova, M.D., Mary Machulda, Ph.D., Patricia Maus, RN, M.S., Jeffrey Staab, M.D., Cosima Swintak, M.D., Kristin Vickers Douglas, Ph.D., Cynthia Harbeck-Weber, Ph.D., Michael Zaccariello, Ph.D., Charlene Nelson

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:  Speaker:  Katherine Burdick, Ph.D.:

Manufacturer(s) Providers(s):  Boehringer Ingelheim; Neuralstem, Takeda-Lundbeck

Product(s)/Device(s):  pramipexole; NSI 189; vortioxetine